217

Last update : 09/05/2017

EMES - Pragmatic pharmacoeconomic assessment of Sinovial® in the treatment of gonarthrosis

Head : Moore Nicholas, Service de Pharmacologie, CIC-P 0005-INSERM U657- Université Bordeaux Segalen

Main objective

The objective was to compare the cost of two therapeutic strategies: Sinovial® and other care versus other care alone.

Inclusion criteria

Patient agreed to participate in this study and having signed the consent form; Patient having had a first injection of Sinovial® between 01/01/2003 and 31/03/2003; Patient having never previously received viscosupplementation treatment; Patient aged 20 years and over; Patient affiliated to the general health insurance system for at least 12 months at the time of first injection

Last update : 09/05/2017

NutriMay - Food, Nutrition and Health in Mayotte: 2006 NutriMay Study

Head : Deschamps Valerie, Unité de surveillance et d’épidémiologie nutritionnelle

Version 1

218

Last update : 09/05/2017

NutriMay - Food, Nutrition and Health in Mayotte: 2006 NutriMay Study

Head : Deschamps Valerie, Unité de surveillance et d’épidémiologie nutritionnelle

Main objective

To describe food consumption, physical activity and nutrition status of the population living in Mayotte, with particular focus on children under 5 years old and women of childbearing age.

Inclusion criteria

Individuals living in an ordinary household in Mayotte and capable of understanding the aims of the study.

Last update : 09/05/2017

ARCHIMED VILLE - Prevention of venous thromboembolic events with Arixtra 2.5mg for medical ill patients in general practice

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Version 1

219

Last update : 01/01/2020

ARCHIMED VILLE - Prevention of venous thromboembolic events with Arixtra 2.5mg for medical ill patients in general practice

Head : Leclerc-Zwirn Christel, Laboratoire GSK

Main objective

Evaluate the average duration of treatment via ARIXTRA® 2.5 mg with thromboprophylaxis in ambulatory general practice

Inclusion criteria

Patient of at least 18 years of age,
-bedridden or with reduced mobility,
-for whom a treatment via ARIXTRA® 2.5 mg is initiated with thromboprophylaxis.

Last update : 01/01/2020

- Survey on homeless people in Paris (1994-1995)

Head : MARPSAT Maryse

Version 1

220

Last update : 10/20/2017

- Survey on homeless people in Paris (1994-1995)

Head : MARPSAT Maryse

Main objective

To study the conditions under which surveys of this type are conducted and extended on a larger scale, and to prepare recommendations for the purpose of achieving a better inclusion of homeless people in the general census of the population, as well as in surveys that are regularly carried out only among those with housing. A first examination of the processes leading to homelessness was also expected.

Inclusion criteria

Persons 18 years of age or older, without a home or having housing but going to food and hot meal distribution centres and/or spending the night in shelters (emergency and long-term).

Last update : 10/20/2017

- 2008 Health and nutrition Barometer

Head : Escalon Hélène, Département Enquêtes et Analyses Statistiques
Beck François, Responsable du département Enquêtes et Analyses Statistiques

Version 1

221

Last update : 01/01/2018

- 2008 Health and nutrition Barometer

Head : Escalon Hélène, Département Enquêtes et Analyses Statistiques
Beck François, Responsable du département Enquêtes et Analyses Statistiques

Main objective

Evaluate diet and physical activity behaviors, attitudes and knowledge of french people

Inclusion criteria

Querying people in households:
-equipped with a landline telephone (white, orange or red list)
-equipped solely with a mobile telephone
- and fully unbundled

Last update : 01/01/2018

EPIPOI - Cohort of Overweight Children or Children At Risk of Being Overweight (Haute-Garonne): Screening and Management

Head : Jouret Béatrice, INSERM U558

Version 1

222

Last update : 09/05/2017

EPIPOI - Cohort of Overweight Children or Children At Risk of Being Overweight (Haute-Garonne): Screening and Management

Head : Jouret Béatrice, INSERM U558

Main objective

The general aims of the EPIPOI study are:
– To screen overweight children or children at the risk of being overweight at 3-4 years old and who are then followed up by their treating physicians with or without support from RéPOP (paediatric obesity prevention and management networks) in Midi-Pyrénées (RéPOP Toulouse);
– to carry out educational intervention programmes for children and to assess their effectiveness;
– to train private practitioners in screening and managing overweight and obese children;
– to determine the prevalence of excess weight and associated factors in children 3-4 years old.
– to characterize the life styles of children aged 3-4 years old.

Inclusion criteria

Overweight children or children at risk of being overweight from voluntary preschools in Haute-Garonne.

Last update : 09/05/2017